Blueberries Medical Corp. Announces C$1.05 Million Private Placement
Toronto, Canada, March 07, 2025 – Blueberries Medical Corp. (CSE: BBM, OTC: BBRRF, FRA: 1OA) (the “Company” or “Blueberries”), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is thrilled to announce a non-brokered private placement to raise funds for business expansion and operational growth. The Offering consists of the sale of 96,064,935 common shares (“Common Shares”) at a price of C$0.011 per Common Share, which equates to an approximate gross proceeds of C$1.05 million (or approximately US$740,000).
Funding for Business Growth
The net proceeds from the sale of the Common Shares are anticipated to be utilized primarily for expanding operations, with the remaining funds allocated for general corporate and working capital purposes. Blueberries aims to leverage these funds to strengthen its market position and capitalize on the growing demand for medicinal cannabis and cannabis-derived products in Latin America.
Investor Opportunities
This private placement presents an excellent opportunity for investors to invest in a company with a solid foundation and a clear growth strategy. Blueberries Medical Corp. has made significant strides in the Latin American cannabis market, with a strong focus on research and development, regulatory compliance, and sustainable cultivation practices. The proceeds from this financing will further bolster the company’s capabilities and enable it to capitalize on the burgeoning cannabis industry in the region.
Impact on the Industry and Consumers
Blueberries’ private placement is a testament to the growing investor interest in the Latin American cannabis market. As more countries in the region legalize medicinal and recreational cannabis, companies like Blueberries are poised to reap the benefits of this burgeoning industry. This investment will not only help Blueberries expand its operations but also contribute to the growth of the Latin American cannabis market as a whole.
Global Implications
The cannabis industry is experiencing a global resurgence, with countries around the world reevaluating their stance on cannabis legalization. Blueberries’ private placement is an indicator of the growing investor confidence in this sector. As more companies enter the market and invest in research and development, we can expect to see a surge in new products, innovative technologies, and improved production methods. This, in turn, will lead to increased accessibility, affordability, and quality of cannabis products for consumers around the world.
Conclusion
Blueberries Medical Corp.’s C$1.05 million private placement is a significant step forward for the company as it seeks to expand its operations and capitalize on the growing demand for medicinal cannabis and cannabis-derived products in Latin America. This investment will not only bolster Blueberries’ position in the market but also contribute to the overall growth of the Latin American cannabis industry. As the global cannabis market continues to evolve, we can expect to see more companies following suit and investing in this promising sector. Stay tuned for further updates on Blueberries Medical Corp.’s journey and the broader cannabis industry landscape.
- Blueberries Medical Corp. announces non-brokered private placement to raise C$1.05 million
- Proceeds to be used for business expansion and operational growth
- Investment opportunity for those interested in the Latin American cannabis market
- Contributes to the growth of the Latin American cannabis industry
- Indicates growing investor confidence in the global cannabis sector
